Users Online Now:
2,275
(
Who's On?
)
Visitors Today:
775,964
Pageviews Today:
1,277,332
Threads Today:
508
Posts Today:
8,785
01:03 PM
Directory
Adv. Search
Topics
Forum
Back to Forum
Back to Thread
REPLY TO THREAD
Subject
Covid: Blood thinner ineffective for patients, trial finds - Addenbrooke's Hospital and University of Cambridge
User Name
Font color:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Indigo
Violet
Black
Font:
Default
Verdana
Tahoma
Ms Sans Serif
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
[quote:S-man:MV81Mjk1ODExXzk3NjEyMjY4XzMzNjMwMjEx] In the context of the above on clotting by Anna Aksenova from 2020, this has to be one of the biggest 'duh' moments since the dark ages! duh...... https://www.nature.com/articles/d41586-022-02286-7 [b]"If the spike protein is the trigger for abnormal clots, that [color=red]raises the question of whether COVID-19 vaccines, which contain the spike or instructions for making it, can induce them as well.[/color]"[/b] [b]Article also mentions amyloid, prions, CJD...[/b] Trials must be held. Justice must be served. MHRA and CDC/FDA knew all of this. [/quote]
Original Message
A possible treatment for severe Covid "puts patients at risk for no clear benefit", a trial found.
More than 1,000 people took part in the UK-wide trial of the blood thinner Apixaban while in hospital with Covid.
The Addenbrooke's Hospital and University of Cambridge study aims to find a treatment to prevent death from Covid, and readmission to hospital.
It found the drug had no impact, but some patients did experience side effects including major bleeding.
Dr Mark Toshner, joint chief investigator for the trial, said it had been assumed that Apixaban could help patients recover from severe Covid.
"This trial is the first robust evidence that longer anticoagulation after acute Covid-19 puts patients at risk for no clear benefit," he said.
"Our hope is that these results will stop this drug being needlessly prescribed to patients with Covid-19 and we can change medical practice."
[
link to www.bbc.co.uk (secure)
]
They are really panicking now.
Pictures (click to insert)
General
Politics
Bananas
People
Potentially Offensive
Emotions
Big Round Smilies
Aliens and Space
Friendship & Love
Textual
Doom
Misc Small Smilies
Religion
Love
Random
View All Categories
|
Next Page >>